✦ LIBER ✦

Crosslinking of chromosomal antigen common in human tumors to DNA by cis-diamminedichloroplatinum (II)

✍ Scribed by R. Oliński; Z. Wojtkowiak

Publisher: Springer
Year: 1985
Tongue: English
Weight: 460 KB
Volume: 10
Category: Article
ISSN: 0301-4851
DOI: 10.1007/bf00778527

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cis-diamminedichloroplatinum(II) augment

Cis-diamminedichloroplatinum(II) augments expression of tumor-associated antigens on human gastric cancer cell line KATO-3 and increases susceptibility and binding of tumor cells to various cytotoxic effector cells

✍ Hayashi, Hitoshi; Nio, Yoshinori; Kawabata, Kazuya; Araya, Shinichi; Imamura, Ma 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 809 KB

Previous studies have demonstrated the immunomodulatory effects of cisplatin under certain conditions. The present study was designed to clarify whether cisplatin modulates the expression of surface antigens, especially human leukocyte antigen (HLA), on human tumor cell lines and/or augments the sus

Inhibition of cis-diamminedichloroplatin

Inhibition of cis-diamminedichloroplatinum (II)-induced DNA interstrand cross-link removal by 7-ethyl-10-hydroxy-camptothecin in HST-1 human squamous-carcinoma cells

✍ Naoko Masumoto; Shuji Nakano; Taito Esaki; Hiromitsu Fujishima; Takashi Tatsumot 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 638 KB

The combination of cis-diamminedichloroplatinum(ll) (CDDP) and 7-ethyl-I0-[4-( I -pipmidino)-I -piperidino]carbonyloxycamptothecin (CPT-I I), a topoisomerase-I inhibitor, has been shown to be synergistic in vitro and clinically active against several human cancers refractory to chemotherapy. To eluc